SCHEMBL28558423

SCHEMBL28558423

COc1ccc(C[C@H](OC(N)=O)C(=O)N(C)OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.48
▸ FAAH O00519 1/20 0.47
▸ PPARG P37231 3/20 0.45
▸ PPARA Q07869 3/20 0.45
▸ SLC6A4 P31645 1/20 0.43
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ PPARD Q03181 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HTT P42858 3/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ PARP10 Q53GL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28558424 1.00 LDHA (0.48) LDHAFAAHPPARGPPARASLC6A4
SCHEMBL28487501 0.86 SRR (0.46) FAAHPPARGPPARAPPARD
SCHEMBL28549393 0.83 LDHA (0.56) LDHAPPARGPPARASLC6A4CYP2C19
SCHEMBL28711821 0.80 PPARG (0.53) LDHAPPARGPPARAALDH1A1
SCHEMBL28119602 0.80 PPARG (0.53) LDHAPPARGPPARAALDH1A1
SCHEMBL28570415 0.78 SMN1; SMN2 (0.50) LDHAPPARGPPARASLC6A4CYP2C19
SCHEMBL28570416 0.78 SMN1; SMN2 (0.50) LDHAPPARGPPARASLC6A4CYP2C19
SCHEMBL29015336 0.77 LMNA (0.44) FAAHCYP1A2HTTSMN1; SMN2CYP3A4
SCHEMBL28558905 0.77 LDHA (0.49) LDHAPPARGPPARASLC6A4CYP2C19
SCHEMBL28558904 0.77 LDHA (0.49) LDHAPPARGPPARASLC6A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107848962-B Urea derivative or pharmacologically acceptable salt thereof 杏林制药株式会社 2021-04-09 — — CN disclosed
Send feedback